🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study of Treatment of Thoracic Aortic Aneurysms and Dilatation in Combination With Tricuspid and Bicuspid Aortic Valves.

Recruitingn/aAges 45 Years - 75 YearsAllTomsk National Research Medical Center of the Rus…
NCT04372563 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Clarification of indications for surgical correction in patients with borderline expansion of the ascending aorta

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Extension of the ascending aorta less than 55 mm 2. Tricuspid Aortic Valves. 3. Extension of the ascending aorta more than 45 mm Exclusion Criteria: 1. Age less 45 years 2. Age more 75 years 3. Multiple organ failure 4. oncological disease
💊

What it tests

  • aortic prosthetics
📍

Where

2 sites
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Tomsk, Russia
Tomsk National Research Medical Center of the Russian Academy of Sciences
Tomsk, Russia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy